d-Aspartic acid ameliorates painful and neuropsychiatric changes and reduces β-amyloid Aβ1-42 peptide in a long lasting model of neuropathic pain

Neurosci Lett. 2017 Jun 9:651:151-158. doi: 10.1016/j.neulet.2017.04.041. Epub 2017 May 6.

Abstract

Depressive symptoms and other neuropsychiatric dysfunctions are common in neurodegenerative disorders, including chronic pain and dementia. A correlation between the β-amyloid protein accumulation and the development of depression has been suggested, however the underlying mechanisms are unknown. d-Aspartate (d-Asp) is a free d-amino acid found in the mammalian brain and involved in neurological and psychiatric processes, such as cognition and affective disorders. In this study we have investigated the effects of a repeated treatment with d-Asp in a long-lasting (12 months) model of neuropathic pain, the spared nerve injury (SNI), in mice. Specifically, we evaluated i) the pain sensitivity and related emotional/cognitive dysfunctions induced by SNI, ii) possible changes in the β-amyloid protein accumulation in specific brain regions involved in pain mechanisms ii) possible changes in steroids level in neuropathic animals with or without d-Asp in the same brain areas. SNI mice showed an increase of the insoluble form of Aβ1-42 at hippocampal level and displayed cognitive impairments, stereotypical and depressive-like behaviours. d-Asp treatment reduced abnormal behaviours and normalized the β-amyloid protein expression. Moreover, d-Asp dramatically increased steroids level measured in the prefrontal cortex and in the hippocampus. Our findings provide new insights into pain mechanisms and suggest a possible role of β-amyloid protein in neuropsychiatric dysfunctions associated with chronic pain.

Keywords: Depression; Hippocampus; Neuropathic pain; β-amyloid.

MeSH terms

  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Behavior, Animal / drug effects
  • D-Aspartic Acid / administration & dosage*
  • Depression / drug therapy*
  • Depression / metabolism
  • Disease Models, Animal
  • Gonadal Steroid Hormones / metabolism
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Hyperalgesia / drug therapy
  • Hyperalgesia / metabolism
  • Male
  • Mice
  • Neuralgia / drug therapy*
  • Neuralgia / metabolism
  • Pain Threshold / drug effects
  • Peptide Fragments / metabolism*
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / metabolism*

Substances

  • Amyloid beta-Peptides
  • Gonadal Steroid Hormones
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • D-Aspartic Acid